195 related articles for article (PubMed ID: 22672528)
1. TRAIL and vitamins: opting for keys to castle of cancer proteome instead of open sesame.
Farooqi AA; Bhatti S; Ismail M
Cancer Cell Int; 2012 Jun; 12(1):22. PubMed ID: 22672528
[TBL] [Abstract][Full Text] [Related]
2. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy.
Long JS; Ryan KM
Oncogene; 2012 Dec; 31(49):5045-60. PubMed ID: 22310284
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications.
Shankar S; Srivastava RK
Drug Resist Updat; 2004 Apr; 7(2):139-56. PubMed ID: 15158769
[TBL] [Abstract][Full Text] [Related]
4. TRAIL and chemotherapeutic drugs in cancer therapy.
Wu XX; Ogawa O; Kakehi Y
Vitam Horm; 2004; 67():365-83. PubMed ID: 15110186
[TBL] [Abstract][Full Text] [Related]
5. Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis.
Philipp S; Sosna J; Plenge J; Kalthoff H; Adam D
Cell Commun Signal; 2015 Apr; 13():25. PubMed ID: 25925126
[TBL] [Abstract][Full Text] [Related]
6. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
Zhang Y; Zhang B
Mol Cancer Res; 2008 Dec; 6(12):1861-71. PubMed ID: 19074831
[TBL] [Abstract][Full Text] [Related]
7. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of CD95 and the TRAIL death receptors.
Gerspach J; Pfizenmaier K; Wajant H
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):294-310. PubMed ID: 21762072
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer proteome takes more than two to tango on TRAIL: beat them at their own game.
Farooqi AA; Fayyaz S; Tahir M; Iqbal MJ; Bhatti S
J Membr Biol; 2012 Dec; 245(12):763-77. PubMed ID: 22899350
[TBL] [Abstract][Full Text] [Related]
11. Pathways involved in proliferating, senescent and immortalized keratinocyte cell death mediated by two different TRAIL preparations.
Qin JZ; Bacon PE; Chaturvedi V; Bonish B; Nickoloff BJ
Exp Dermatol; 2002 Dec; 11(6):573-83. PubMed ID: 12473065
[TBL] [Abstract][Full Text] [Related]
12. TRAIL and apoptosis induction by TNF-family death receptors.
Wang S; El-Deiry WS
Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624
[TBL] [Abstract][Full Text] [Related]
13. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of response to TRAIL in killing of normal and cancer cells.
Kim K; Fisher MJ; Xu SQ; el-Deiry WS
Clin Cancer Res; 2000 Feb; 6(2):335-46. PubMed ID: 10690508
[TBL] [Abstract][Full Text] [Related]
15. Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra.
Farooqi AA; Gadaleta CD; Ranieri G; Fayyaz S; Marech I
Curr Genomics; 2017 Feb; 18(1):27-38. PubMed ID: 28503088
[TBL] [Abstract][Full Text] [Related]
16. Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway.
Khan M; Bi Y; Qazi JI; Fan L; Gao H
Mol Med Rep; 2015 Jan; 11(1):257-62. PubMed ID: 25333675
[TBL] [Abstract][Full Text] [Related]
17. Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.
Mazurek N; Byrd JC; Sun Y; Hafley M; Ramirez K; Burks J; Bresalier RS
Cell Death Differ; 2012 Mar; 19(3):523-33. PubMed ID: 21941373
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in established and primary glioma cell lines.
Jaganathan J; Petit JH; Lazio BE; Singh SK; Chin LS
Neurosurg Focus; 2002 Sep; 13(3):ecp1. PubMed ID: 15844877
[TBL] [Abstract][Full Text] [Related]
19. The essential role of the mitochondria-dependent death-signaling cascade in chemotherapy-induced potentiation of Apo2L/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death.
Nguyen DM; Yeow WS; Ziauddin MF; Baras A; Tsai W; Reddy RM; Chua A; Cole GW; Schrump DS
Cancer J; 2006; 12(4):257-73. PubMed ID: 16925970
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside.
Fayyaz S; Javed Z; Attar R; Farooqi AA; Yaylim I; Ahmad A
Semin Cancer Biol; 2019 Oct; 58():56-64. PubMed ID: 30716480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
